EQUITY RESEARCH

Influential opinions and insights on companies

Our equity analysts ask the right questions, dig deeper for answers and find details others miss. Our research division covers key Canadian healthcare companies to understand how they operate, recognize their relative strengths and weaknesses, and determine the impact of clinical and commercial developments and competitive events.

Specialized equity research that gets attention

Our analysts make influential buy, sell and hold recommendations in healthcare and biotechnology, gather industry knowledge, and provide insightful market intelligence to help guide our investor clients.

Charting what’s new in biotech: Bloom Burton’s Top Ideas; Healthcare Sector Review/Preview

Our Top Ideas; Healthcare Sector Review/Preview report, published annually, is essential reading for institutional investors to track historical sector performance and glean insight for the upcoming year, including milestones that could impact share performance.

Distribution of healthcare research

Bloom Burton’s research products are disseminated simultaneously to all our customers who are authorized to receive them. Request to be added to Bloom Burton’s equity research distribution list. Email Brian Bloom at bbloom@bloomburton.com.

The Therapeutic Window

The 13th edition of The Therapeutic Window, a report to be used by investors and industry executives as a directory of products (both marketed and in development) and upcoming milestones in the publicly-listed Canadian healthcare sector is out now.

Research Coverage

AbCellera Biologics (NASDAQ: ABCL)
Aurinia Pharmaceuticals (NASDAQ: AUPH, TSX: AUP)
BioSyent Inc. (TSX-V: RX)
CareRX (TSX: CRRX)
Cybin (CBOE: CYBN / NYSE American: CYBN)
DRI Healthcare Trust (TSX: DHT-U; TSX: DHT/U)
ESSA Pharma (NASDAQ: EPIX, TSX:EPI)
HLS Therapeutics (TSX:HLS)
Knight Therapeutics (TSX:GUD)
Medexus Pharmaceuticals (TSX: MDP)
Medicenna Therapeutics Corp. (NASDAQ: MDNA, TSX:MDNA)
Microbix Biosystems Inc. (TSX:MBX)
Repare Therapeutics Inc. (NASDAQ: RPTX)
Xenon Pharmaceuticals (NASDAQ: XENE)
Zymeworks Inc. (NYSE: ZYME)

For more information on our equity research services, please contact:

David Martin
dmartin@bloomburton.com
416-642-8865